Other
12 months or more
Morgan Stanley 12 months or more decreased by 19.8% to $24.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 39.4%, from $39.95B to $24.21B. Over 4 years (FY 2021 to FY 2025), 12 months or more shows an upward trend with a 103.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ1 2026May 5, 2026
Metric ID:
other_debt_securities_available_for_sale_continuous_unre_52a0a6Historical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.78B | $11.01B | $14.22B | $12.88B | $19.24B | $39.12B | $40.60B | $53.77B | $57.98B | $54.77B | $53.70B | $49.65B | $44.15B | $39.95B | $44.98B | $40.73B | $30.17B | $24.21B |
| QoQ Change | — | +520.1% | +29.2% | -9.4% | +49.4% | +103.3% | +3.8% | +32.4% | +7.8% | -5.5% | -1.9% | -7.5% | -11.1% | -9.5% | +12.6% | -9.4% | -25.9% | -19.8% |
| YoY Change | — | — | — | — | +983.9% | +255.5% | +185.6% | +317.5% | +201.4% | +40.0% | +32.3% | -7.6% | -23.9% | -27.1% | -16.2% | -18.0% | -31.7% | -39.4% |
Range$1.78B – $57.98B
CAGR+84.9%
Avg YoY Growth+132.3%
Median YoY Growth+12.3%
Current Streak3 quarters decline
12 months or more at Other Companies
Frequently Asked Questions
- What is Morgan Stanley's 12 months or more?
- Morgan Stanley (MS) reported 12 months or more of $24.21B in Q1 2026.
- How has Morgan Stanley's 12 months or more changed year-over-year?
- Morgan Stanley's 12 months or more decreased by 39.4% year-over-year, from $39.95B to $24.21B.
- What is the long-term trend for Morgan Stanley's 12 months or more?
- Over 4 years (2021 to 2025), Morgan Stanley's 12 months or more has grown at a 103.0% compound annual growth rate (CAGR), from $1.78B to $30.17B.